Non-interventional study
Real-world post-authorization effectiveness study (PAES) of pembrolizumab for the treatment of NSCLC across races, ethnicities, and age groups (MK-3475-G18)
United States
EU PAS number:
EUPAS1000000576
First published:
12/06/2025
StudyPlanned
Real-life data study of the French cohort of patients with Rendu Osler disease treatment with bevacizumab:the CoBevaRO study.
France
EU PAS number:
EUPAS1000000548
First published:
06/05/2025
StudyOngoing
Real-world effectiveness of pembrolizumab among patients with TMB-H advanced solid tumors (MK-3475-G34)
United States
EU PAS number:
EUPAS1000000542
First published:
06/05/2025
StudyOngoing
Prospective Registry-Based Study Evaluating the Effectiveness and Safety of Odevixibat in Participants With Alagille Syndrome (ALGS)
United States
EU PAS number:
EUPAS1000000441
First published:
06/05/2025
StudyOngoing
AN ITALIAN RETROSPECTIVE-PROSPECTIVE OBSERVATIONAL STUDY ON THE USE OF ZANUBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (AZALEA)
Italy
EU PAS number:
EUPAS1000000437
First published:
10/03/2025
StudyOngoing
Pergoveris patients’ profile and outcome response measurement in IVF/ICSI autologous cycles (PERFORM)
France
Germany
Greece
Italy
Norway
Romania
Spain
Switzerland
EU PAS number:
EUPAS1000000435
First published:
20/01/2025
StudyOngoing
Paternal exposure to valproate and the risk of neurodevelopmental disorders in children
Norway
Taiwan
EU PAS number:
EUPAS1000000417
First published:
14/04/2025
StudyOngoing
Characterize infections and outcomes developed in relapsed/refractory multiple myeloma (RRMM) patients treated with Teclistamab (SPOT)
Portugal
EU PAS number:
EUPAS1000000414
First published:
11/03/2025
StudyOngoing
Safety and effectiveness of LORLAtinib as a FIRST-line treatment in an ALK-positive Advanced Non-Small Cell Lung Cancer Spanish population. (LORLA-FIRST).
Spain
EU PAS number:
EUPAS1000000406
First published:
04/06/2025
StudyPlanned
Comparative Effectiveness of Sotorasib Versus Docetaxel Monotherapy in Second Line and Beyond (2L+) Among Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in the Cancer Analysis System Database in England (20240164)
United Kingdom
EU PAS number:
EUPAS1000000405
First published:
16/04/2025
StudyOngoing